Cargando…
To whom recommend intensive treatment for hypertension?
Arterial hypertension is the main identifiable cardiovascular risk factor, and although the benefit of blood pressure reduction is universally acknowledged, the scientific community has long been divided over the therapeutic blood pressure targets to be reached, also considering the estimated overal...
Autores principales: | Volpe, Massimo, Gallo, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270960/ https://www.ncbi.nlm.nih.gov/pubmed/32523464 http://dx.doi.org/10.1093/eurheartj/suaa085 |
Ejemplares similares
-
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
por: Gallo, Giovanna, et al.
Publicado: (2022) -
The enigma of resistant hypertension: from lifestyle changes and pharmacological treatment to renal denervation
por: Volpe, Massimo, et al.
Publicado: (2022) -
Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?
por: Gagelmann, Nico, et al.
Publicado: (2021) -
Endothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
por: Gallo, Giovanna, et al.
Publicado: (2022) -
Continuous education in intensive care for physicians in Brazil: for whom and their needs
por: Goldwasser, R, et al.
Publicado: (2007)